(Q39273435)

10 September 2017

title

Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment (English)

1 reference

10 September 2017

1 reference

cutaneous leishmaniasis

1 reference

V Mosimann

1

1 reference

10 September 2017

A Neumayr

series ordinal

2

1 reference

10 September 2017

C Hatz

series ordinal

3

1 reference

10 September 2017

J A Blum

series ordinal

4

1 reference

10 September 2017

publication date

9 July 2013

1 reference

10 September 2017

1 reference

10 September 2017

volume

41

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

1177-1182

1 reference

Treatment of cutaneous leishmaniasis among travellers

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Treatment of cutaneous leishmaniasis in travelers 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

New world cutaneous leishmaniasis in travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

[Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Miltefosine for new world cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Efficacy of Miltefosine for the Treatment of American Cutaneous Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Traitement des leishmanioses en France : proposition d’un référentiel consensuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0500-5

Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

12 December 2020

[The therapy of cutaneous and mucocutaneous leishmaniasis]

1 reference

12 December 2020

Cutaneous leishmaniasis

1 reference

12 December 2020

Cutaneous leishmaniasis. Treatment with combined cryotherapy and intralesional stibogluconate injection

1 reference

12 December 2020

10.1007/S15010-013-0500-5

Identifiers

DOI

1 reference

10 September 2017

1 reference